The SEDASYS System has been approved by the U.S. Food and Drug Administration for the delivery of the drug propofol to adults undergoing sedation for esophageal and colon cancer screenings.
The guidance document includes recommendations for practicing anesthesiologists and directors of anesthesia services at facilities that will incorporate the CAPS devices into their practices.
More Articles on Anesthesia:
12 Challenges for Anesthesia Groups Next Year
Anesthesia Group Acquisition Activity Grows in 2013
Presence United Samaritans Medical Center Honors Dr. Carmen Rocco
